利记·sbobet(中国)-唯一官方网站

Founded in 1994, Shanghai Fosun Pharmaceutical (Group) Co., Ltd.* ("Fosun Pharma"; stock code: 600196.SH, 02196.HK) is a global innovation-driven pharmaceutical and healthcare industry group. Fosun Pharma directly operates businesses including pharmaceuticals, medical devices, medical diagnosis, and healthcare services. As a shareholder of Sinopharm Co., Ltd., Fosun Pharma expands its areas in the pharmaceutical distribution and retail business.


Fosun Pharma is patient-centered and unmet clinical needs-oriented. Through diversified and multi-level cooperation models such as independent research and development, cooperative development, license-in, and industrial investment, the company continues to enrich its innovative product pipeline and focus on differentiated product R&D with high-tech barriers, to continuously enhance the value of its pipeline. Fosun Pharma’s innovative products focus on core therapeutic areas such as solid tumors, hematologic tumors and immunity inflammation. It also strengthens core technology platforms such as antibodies/ADC, cell therapy, and small molecules.


Guided by the 4IN strategy (Innovation, Internationalization, Intelligentization, and Integration), Fosun Pharma adheres to the business philosophy of “Innovation for Good Health", continues to promote innovative transformation, actively deploys internationalization, strengthens business focus by product lines, promotes integrated operations and efficiency improvement, and is dedicated to being the global leading integrator of pharmaceutical and healthcare innovation.


  • 41,400 Million
    FY2023 Revenue
  • 2,011 Million
    FY2023 Net Profit after deducting extraordinary gain or loss attributable to owners of the parent
  • 5,937 Million
    FY2023 R&D Expenditure
  • 39,309
    Global Employees
  • Five-Star (Excellence)
    2022 Corporate Social Responsibility Report Rating
  • A
    MSCI ESG Rating
As of June 30, 2024
Unit: RMB million
  • Mission

    Better Health for Families Worldwide

  • Vision

    We are dedicated to being the global leading integrator of pharmaceutical and healthcare innovation

  • Values

    1. Care for Life
    2. Continuous Innovation
    3. Pursuit of Excellence
    4. Sustainable Partnership